- 专利标题: C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
-
申请号: US17342941申请日: 2021-06-09
-
公开(公告)号: US20210323997A1公开(公告)日: 2021-10-21
- 发明人: Jie CHEN , Yan Chen , Ira B. Dicker , Richard A. Hartz , Nicholas A. Meanwell , Beata Nowicka-Sans , Alicia Regueiro-Ren , Sing-Yuen Sit , Ny Sin , Jacob Swidorski , Brian Lee Venables
- 申请人: ViiV HEALTHCARE UK (NO.5) LIMITED
- 申请人地址: GB Brentford
- 专利权人: ViiV HEALTHCARE UK (NO.5) LIMITED
- 当前专利权人: ViiV HEALTHCARE UK (NO.5) LIMITED
- 当前专利权人地址: GB Brentford
- 主分类号: C07J53/00
- IPC分类号: C07J53/00 ; C07J63/00 ; C12N9/50 ; A61P31/18
摘要:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
信息查询